Copper Complexes as Anticancer Agents
The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Abstract
Metal-based antitumor drugs play a relevant role in antiblastic chemotherapy. Cisplatin is regarded as one of the most effective drugs, even if severe toxicities and drug resistance phenomena limit its clinical use. Therefore, in recent years there has been a rapid expansion in research and development of novel metal-based anticancer drugs to improve clinical effectiveness, to reduce general toxicity and to broaden the spectrum of activity. The variety of metal ion functions in biology has stimulated the development of new metallodrugs other than Pt drugs with the aim to obtain compounds acting via alternative mechanisms of action. Among non-Pt compounds, copper complexes are potentially attractive as anticancer agents. Actually, since many years a lot of researches have actively investigated copper compounds based on the assumption proposal that endogenous metals may be less toxic. It has been established that the properties of copper-coordinated compounds are largely determined by the nature of ligands and donor atoms bound to the metal ion. In this review, the most remarkable achievements in the design and development of copper(I, II) complexes as antitumor agents are discussed. Special emphasis has been focused on the identification of structure-activity relationships for the different classes of copper(I,II) complexes. This work was motivated by the observation that no comprehensive surveys of copper complexes as anticancer agents were available in the literature. Moreover, up to now, despite the enormous efforts in synthesizing different classes of copper complexes, very few data concerning the molecular basis of the mechanisms underlying their antitumor activity are available. This overview, collecting the most significant strategies adopted in the last ten years to design promising anticancer copper( I,II) compounds, would be a help to the researchers working in this field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Revised methods for the Salmonella mutagenicity test
Maron, D. M., & Ames, B. N. (1983) · Mutation Research/Environmental Mutagenesis and Related Subjects · doi:10.1016/0165-1161(83)90010-9 · Cited by 7,386
Comprehensive Coordination Chemistry
Eaborn, C. (1988) · Journal of Organometallic Chemistry · doi:10.1016/0022-328x(88)83103-6 · Cited by 7,163
Metals, Toxicity and Oxidative Stress
Valko, M., Morris, H., & Cronin, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764635 · Cited by 5,018 · cited 1×
“Anyway, when considering copper as a metal participating in Fenton chemistry, it has to be reminded that intracellular free copper is limited to less than one free copper ion per cell, thus suggesting a significant overcapacity for chelation of copper in the cell [25].”
Background[1] Role of free radicals and catalytic metal ions in human disease: An overview
Halliwell, B., & Gutteridge, J. M. C. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86093-b · Cited by 4,994 · cited 2×
“The major functions of copper–biological compounds involve oxidation–reduction reactions in which copper containing biological molecules react directly with molecular oxygen to produce free radicals [12,13].”
BackgroundVascular endothelial growth factor (VEGF) and its receptors
NEUFELD, G., COHEN, T., GENGRINOVITCH, S., & POLTORAK, Z. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.9 · Cited by 3,483
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Copper toxicity, oxidative stress, and antioxidant nutrients
Gaetke, L. (2003) · Toxicology · doi:10.1016/s0300-483x(03)00159-8 · Cited by 2,160
Vulpe, C., Levinson, B., Whitney, S., Packman, S., & Gitschier, J. (1993) · Nature Genetics · doi:10.1038/ng0193-7 · Cited by 1,418
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
Tanzi, R. E., Petrukhin, K., Chernov, I., Pellequer, J. L., Wasco, W., Ross, B., Romano, D. M., Parano, E., Pavone, L., Brzustowicz, L. M., et al. (1993) · Nature Genetics · doi:10.1038/ng1293-344 · Cited by 1,375
The biological chemistry of the elements: the inorganic chemistry of life
(1992) · Choice Reviews Online · doi:10.5860/choice.30-0286 · Cited by 1,321
The biological chemistry of the elements
(1993) · Science of The Total Environment · doi:10.1016/0048-9697(93)90224-t · Cited by 1,173
Role of metals in oxygen radical reactions
Aust, S. D., Morehouse, L. A., & Thomas, C. E. (1985) · Journal of Free Radicals in Biology & Medicine · doi:10.1016/0748-5514(85)90025-x · Cited by 1,145
Pogozelski, W. K., & Tullius, T. D. (1998) · Chemical Reviews · doi:10.1021/cr960437i · Cited by 1,018
Shaw, C. F. (1999) · Chemical Reviews · doi:10.1021/cr980431o · Cited by 990
New metal complexes as potential therapeutics
Zhang, C. X., & Lippard, S. J. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00081-4 · Cited by 946
Fuertes, M. A., Alonso, C., & Pérez, J. M. (2003) · Chemical Reviews · doi:10.1021/cr020010d · Cited by 893
Copper-Dioxygen Complexes. Inorganic and Bioinorganic Perspectives
Kitajima, N., & Moro-oka, Y. (1994) · Chemical Reviews · doi:10.1021/cr00027a010 · Cited by 875
Mechanisms of resistance to cisplatin
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00141-5 · Cited by 869
The Copper Chaperone for Superoxide Dismutase
Culotta, V. C., Klomp, L. W. J., Strain, J., Casareno, R. L. B., Krems, B., & Gitlin, J. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23469 · Cited by 850
Guo, Z., & Sadler, P. J. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990601)38:11<1512::aid-anie1512>3.0.co;2-y · Cited by 834
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
Tucker, O., Dannenberg, A. J., Yang, E. K., Zhang, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., et al. (1999) · PubMed · Cited by 692
Metal complexes in cancer chemotherapy
Keppler, B. K. (1993) · Medical Entomology and Zoology · Cited by 688
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 674
Bcl‐2 family: Life‐or‐death switch
Tsujimoto, Y., & Shimizu, S. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01761-5 · Cited by 667
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
Subbaramaiah, K., & Dannenberg, A. J. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00043-3 · Cited by 649
Linder, M. C. (1991) · Springer eBooks · doi:10.1007/978-1-4757-9432-8 · Cited by 626
Nuclease activity of 1,10-phenanthroline-copper ion
Sigman, D. S. (1986) · Accounts of Chemical Research · doi:10.1021/ar00126a004 · Cited by 611
The Role of Glutathione in Copper Metabolism and Toxicity
Freedman, J. H., Ciriolo, M. R., & Peisach, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83589-x · Cited by 603
Rajendiran, V., Karthik, R., Palaniandavar, M., Stoeckli-Evans, H., Periasamy, V. S., Akbarsha, M. A., Srinag, B. S., & Krishnamurthy, H. (2007) · Inorganic Chemistry · doi:10.1021/ic700755p · Cited by 589
The interactions of metal ions with quinolone antibacterial agents
Turel, I. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00027-9 · Cited by 572
Copper complexes of non-steroidal anti-inflammatory drugs: an opportunity yet to be realized
Weder, J. E., Dillon, C. T., Hambley, T. W., Kennedy, B. J., Lay, P. A., Biffin, J. R., Regtop, H. L., & Davies, N. M. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00086-3 · Cited by 536
Sigman, D. S., Graham, D. R., D'Aurora, V., & Stern, A. M. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86305-6 · Cited by 528
The Haber-Weiss cycle – 70 years later
Koppenol, W. H. (2001) · Redox Report · doi:10.1179/135100001101536373 · Cited by 504
Zhang, T., Otevrel, T., Gao, Z., Gao, Z., Ehrlich, S. M., Fields, J. Z., & Boman, B. M. (2001) · PubMed · Cited by 498
Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development
Lee, J., Prohaska, J. R., & Thiele, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111058698 · Cited by 472
Felson, D. T., Anderson, J. J., & Meenan, R. F. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331001 · Cited by 470
Sporn, M. B., & Suh, N. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.525 · Cited by 439
Carbon—Hydrogen Bonds of DNA Sugar Units as Targets for Chemical Nucleases and Drugs
Pratviel, G., Bernadou, J., & Meunier, B. (1995) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199507461 · Cited by 422
Comprehensive coordination chemistry II: from biology to nanotechnology
(2004) · Choice Reviews Online · doi:10.5860/choice.41-6540 · Cited by 420
The regulatory role of nitric oxide in apoptosis
Kim, P. K. M., Zamora, R., Petrosko, P., & Billiar, T. R. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00088-1 · Cited by 391
Development of the Proteasome Inhibitor PS-341
Adams, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-9 · Cited by 369
Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways
Cummings, B. S., & Schnellmann, R. G. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.8 · Cited by 358
Theophanides, T., & Anastassopoulou, J. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(02)00007-0 · Cited by 349
Recognition of cisplatin adducts by cellular proteins
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00142-7 · Cited by 349
Zhang, P., Gao, W., Turner, S., & Ducatman, B. S. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-1 · Cited by 344
Non-Heme Iron Nitrosyls in Biology
Butler, A. R., & Megson, I. L. (2002) · Chemical Reviews · doi:10.1021/cr000076d · Cited by 343 · cited 1×
“[86] have synthesized copper(II) complexes with nitroprusside as a counterion because of its use in medical practice, thanks to the role of the nitric oxide released [87-89], as well as because of its inductive role in apoptosis [88, 89].”
BackgroundAdsule, S., Barve, V., Chen, D., Ahmed, F., Dou, Q. P., Padhye, S., & Sarkar, F. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060712l · Cited by 334
Daniel, K. G., Chen, D., Orlu, S., Cui, Q. C., Miller, F. R., & Dou, Q. P. (2005) · Breast Cancer Research · doi:10.1186/bcr1322 · Cited by 326
Prognostic significance of angiogenesis in human pancreatic cancer
Ikeda, N., Adachi, M., Taki, T., Huang, C., Hashida, H., Takabayashi, A., Sho, M., Nakajima, Y., Kanehiro, H., Hisanaga, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690248 · Cited by 316
Preclinical Perspectives on Platinum Resistance
Kelland, L. R. (2000) · Drugs · doi:10.2165/00003495-200059004-00001 · Cited by 280
Turnlund, J. R., Keyes, W. R., Anderson, H. L., & Acord, L. L. (1989) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/49.5.870 · Cited by 255
Characterization of Mouse Embryonic Cells Deficient in the Ctr1 High Affinity Copper Transporter
Lee, J., Petris, M. J., & Thiele, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208002200 · Cited by 244
Zhang, S., Zhu, Y., Tu, C., Wei, H., Yang, Z., Lin, L., Ding, J., Zhang, J., & Guo, Z. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.09.014 · Cited by 244
Copper in Medicine: Homeostasis, Chelation Therapy and Antitumor Drug Design
Wang, T., & Guo, Z. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706776055742 · Cited by 233
Li, C. J., Zhang, L. J., Dezube, B. J., Crumpacker, C. S., & Pardee, A. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1839 · Cited by 230
Brem, S. S., Zagzag, D., Tsanaclis, A. M. C., Gately, S. T., Elkouby, M. P., & Brien, S. (1990) · Europe PMC (PubMed Central) · Cited by 229
Structure and function of “metalloantibiotics”
Ming, L. (2003) · Medicinal Research Reviews · doi:10.1002/med.10052 · Cited by 227
Li, Y., & Trush, M. A. (1993) · Carcinogenesis · doi:10.1093/carcin/14.7.1303 · Cited by 227
Ohtsu, H., Shimazaki, Y., Odani, A., Yamauchi, O., Mori, W., Itoh, S., & Fukuzumi, S. (2000) · Journal of the American Chemical Society · doi:10.1021/ja994050j · Cited by 216
Planchon, S. M., Wuerzberger‐Davis, S. M., Frydman, B., Witiak, D. T., Hutson, P. R., Church, D. R., Wilding, G., & Boothman, D. A. (1995) · PubMed · Cited by 202
Zhou, C.-Y., Zhao, J., Wu, Y.-B., Yin, C.-X., & Pin, Y. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.07.011 · Cited by 200
Hirohama, T., Kuranuki, Y., Ebina, E., Sugizaki, T., Arii, H., Chikira, M., Tamil Selvi, P., & Palaniandavar, M. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.02.020 · Cited by 198
Ternary Coordination Complex between Human Serum Albumin, Copper (II), and l-Histidine
Lau, S.-J., & Sarkar, B. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61817-4 · Cited by 197
Nuclease activity of 1,10-phenanthroline-copper: kinetic mechanism
Thederahn, T. B., Kuwabara, M. D., Larsen, T. A., & Sigman, D. S. (1989) · Journal of the American Chemical Society · doi:10.1021/ja00195a057 · Cited by 196
Laussac, J. P., & Sarker, B. (1984) · Biochemistry · doi:10.1021/bi00307a046 · Cited by 193
Overexpression of cyclooxygenase-2 in carcinoma of the pancreas.
Okami, J., Yamamoto, H., Fujiwara, Y., Tsujie, M., Kondo, M., Noura, S., Oshima, S., Nagano, H., Dono, K., Umeshita, K., et al. (1999) · PubMed · Cited by 192
Devereux, M., O Shea, D., Kellett, A., McCann, M., Walsh, M., Egan, D., Deegan, C., Kędziora, K., Rosair, G., & Müller-Bunz, H. (2007) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2007.02.002 · Cited by 192
The Role of Copper in Tumour Angiogenesis
Lowndes, S. A., & Harris, A. L. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-006-9003-7 · Cited by 186
Berners-Price, S. J., & Sadler, P. J. (1988) · Structure and Bonding · doi:10.1007/3-540-50130-4_2 · Cited by 184
Hydroxamic Acids − An Intriguing Family of Enzyme Inhibitors and Biomedical Ligands
Marmion, C. J., Griffith, D., & Nolan, K. B. (2004) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200400221 · Cited by 181
The role of oxidative stress in mechanisms of metal-induced carcinogenesis
Galaris, D., & Evangelou, A. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00212-8 · Cited by 178
Rw, B., THOMSON, J. R., BELL, M. J., & He, S. (1956) · PubMed · Cited by 178
Afrasiabi, Z. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(03)00131-4 · Cited by 176
Yoshii, J., Yoshiji, H., Kuriyama, S., Ikenaka, Y., Noguchi, R., Okuda, H., Tsujinoue, H., Nakatani, T., Kishida, H., Nakae, D., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1537 · Cited by 170
Lovejoy, D. B., & Richardson, D. R. (2002) · Blood · doi:10.1182/blood.v100.2.666 · Cited by 168
Copper deficiency as an anti-cancer strategy.
Goodman, V. L., Brewer, G. J., & Merajver, S. D. (2004) · Endocrine-related cancer · doi:10.1677/erc.0.0110255 · Cited by 168
Filomeni, G., Cerchiaro, G., Ferreira, A. M. D. C., Martino, A. D., Pedersen, J. Z., Rotilio, G., & Ciriolo, M. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610927200 · Cited by 167
Kagawa, T. F., Geierstanger, B. H., Wang, A. H., & Ho, P. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54906-1 · Cited by 161
Meijler, M. M., Zelenko, O., & Sigman, D. S. (1997) · Journal of the American Chemical Society · doi:10.1021/ja962409n · Cited by 160
Afrasiabi, Z., Sinn, E., Chen, J., Ma, Y., Rheingold, A. L., Zakharov, L. N., Rath, N. P., & Padhyé, S. (2003) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(03)00484-5 · Cited by 156
Mechanistic studies on DNA damage by minor groove binding copper-phenanthroline conjugates
Bales, B. C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki856 · Cited by 155
THE COMPARATIVE EFFICACY AND TOXICITY OF SECOND LINE DRUGS IN RHEUMATOID ARTHRITIS
Felson, D. T., Anderson, J., & Meenan, R. F. (1990) · Cited by 153
Frydman, B., Marton, L. J., Sun, J. S., Neder, K., Witiak, D. T., Liu, A. A., Wang, H. M., Mao, Y., Wu, H., Sanders, M. M., et al. (1997) · PubMed · Cited by 152
Copper storage diseases: Menkes, Wilson's, and Cancer
Daniel, K. (2004) · Frontiers in Bioscience · doi:10.2741/1424 · Cited by 146
Devereux, M. M., O′Shea, D., O’Connor, M. J., Grehan, H., Connor, G., McCann, M., Rosair, G. M., Lyng, F. M., Kellett, A., Walsh, M., et al. (2007) · Polyhedron · doi:10.1016/j.poly.2007.05.006 · Cited by 145
Belicchi-Ferrari, M., Bisceglie, F., Casoli, C., Durot, S., Morgenstern‐Badarau, I., Pelosi, G., Pilotti, E., Pinelli, S., & Tarasconi, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049529n · Cited by 137
Vizcaya‐Ruíz, A. D., Rivero‐Müller, A., Ruiz-Ramirez, L., Kass, G. E. N., Kèlland, L. R., Orr, R. M., & Dobrota, M. (2000) · Toxicology in Vitro · doi:10.1016/s0887-2333(99)00082-x · Cited by 135
Barve, V., Ahmed, F., Adsule, S., Banerjee, S., Kulkarni, S., Katiyar, P., Anson, C. E., Powell, A. K., Padhyé, S., & Sarkar, F. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051068y · Cited by 132
Anticopper therapy against cancer and diseases of inflammation and fibrosis
Brewer, G. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03541-5 · Cited by 131
Ferrari, M. B., Bisceglie, F., Pelosi, G., Tarasconi, P., Albertini, R., Dall'Aglio, P. P., Pinelli, S., Bergamo, A., & Sava, G. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2003.09.011 · Cited by 130
Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide
Ganley, B. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00163-8 · Cited by 129
Kalsani, V., Schmittel, M., Listorti, A., Accorsi, G., & Armaroli, N. (2006) · Inorganic Chemistry · doi:10.1021/ic051828v · Cited by 128
Copper(I) transfer into metallothionein mediated by glutathione
Ferreira, A. M. D. C., Ciriolo, M. R., Marcocci, L., & Rotilio, G. (1993) · Biochemical Journal · doi:10.1042/bj2920673 · Cited by 127
Trejo‐Solís, C., Palencia, G., Zuñiga, S., Rodríguez-Ropón, A., Osorio‐Rico, L., Sánchez‐Torres, L. E., Gracia‐Mora, I., Márquez‐Rosado, L., Sánchez, A., Moreno‐García, M. E., et al. (2005) · Neoplasia · doi:10.1593/neo.04607 · Cited by 123
Feun, L. G., Modiano, M., Lee, K. C., Mao, J., Marini, A., Savaraj, N., Plezia, P. M., Almassian, B., Colacino, E., Fischer, J., et al. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0480-0 · Cited by 120
Antholine, W. E., Knight, J. M., & Petering, D. H. (1976) · Journal of Medicinal Chemistry · doi:10.1021/jm00224a030 · Cited by 120
Rodríguez‐Enríquez, S., Vital‐González, P. A., Flores‐Rodríguez, F. L., Marín‐Hernández, Á., Ruíz-Azuara, L., & Moreno‐Sánchez, R. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.02.005 · Cited by 116
Pitié, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.24.4856 · Cited by 116
Rivero‐Müller, A., Vizcaya‐Ruíz, A. D., Plant, N. J., Ruiz, L., & Dobrota, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.002 · Cited by 115
Toxic effects of copper-based antineoplastic drugs (Casiopeinas®) on mitochondrial functions
Marín‐Hernández, Á., Gracia‐Mora, I., Ruíz-Azuara, L., & Moreno‐Sánchez, R. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00212-0 · Cited by 114
The role of copper transporters in the development of resistance to Pt drugs
Safaei, R., Holzer, A. K., Katano, K., Samimi, G., & Howell, S. B. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.05.006 · Cited by 114
Isatin-Schiff base copper(II) complexes and their influence on cellular viability
Cerchiaro, G., Aquilano, K., Filomeni, G., Rotilio, G., Ciriolo, M. R., & Ferreira, A. M. D. C. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.03.013 · Cited by 110
Inhibitors of ribonucleotide reductase
Cory, J. G., Cory, A. H., Rappa, G., Lorico, A., Liu, M., Lin, T., & Sartorelli, A. C. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90105-8 · Cited by 109
Burkitt, M. J. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)34078-1 · Cited by 107
Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas®)
Alemón‐Medina, R., Breña-Valle, M., Muñoz-Sánchez, J. L., Gracia‐Mora, I., & Ruíz-Azuara, L. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0364-9 · Cited by 107
Ritland, S., & Gendler, S. J. (1999) · Carcinogenesis · doi:10.1093/carcin/20.1.51 · Cited by 99
Mutation Analysis and Expression of the Mottled Gene in the Macular Mouse Model of Menkes Disease
Murata, Y., Kodama, H., Abe, T., Ishida, N., Nishimura, M., Levinson, B., Gitschier, J. M., & Packman, S. (1997) · Pediatric Research · doi:10.1203/00006450-199710000-00003 · Cited by 93
Thomas, A. M., Nethaji, M., Mahadevan, S., & Chakravarty, A. R. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00613-x · Cited by 92
Characterization and quantification of copper sulfate-induced vascularization of the rabbit cornea.
Parke, A., Bhattacherjee, P., Palmer, R. M., & Lazarus, N. R. (1988) · Europe PMC (PubMed Central) · Cited by 91
Tardito, S., Bussolati, O., Maffini, M., Tegoni, M., Giannetto, M., Dall’Asta, V., Franchi‐Gazzola, R., Lanfranchi, M., Pellinghelli, M. A., Mucchino, C., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061174f · Cited by 85
Marzano, C., Pellei, M., Alidori, S., Brossa, A., Lobbia, G. G., Tisato, F., & Santini, C. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.11.014 · Cited by 84
Self-citationCaspase-dependent and -independent death pathways in cancer therapy
Kolenko, V. M., Uzzo, R. G., Bukowski, R., & Finke, J. H. (2000) · APOPTOSIS · doi:10.1023/a:1009677307458 · Cited by 81
Sessler, J. L., Doctrow, S. R., McMurry3, T. J., & Lippard, S. J. (2005) · ACS symposium series · doi:10.1021/bk-2005-0903 · Cited by 80
Bortezomib (millennium pharmaceuticals).
Dou, Q. P., & Goldfarb, R. H. (2002) · PubMed · Cited by 66
Non-apoptotic programmed cell death induced by a copper(II) complex in human fibrosarcoma cells
Tardito, S., Bussolati, O., Gaccioli, F., Gatti, R., Guizzardi, S., Uggeri, J., Marchiò, L., Lanfranchi, M., & Franchi‐Gazzola, R. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0183-4 · Cited by 65
Pitié, M., Horn, J. D. V., Brion, D., Burrows, C. J., & Meunier, B. (2000) · Bioconjugate Chemistry · doi:10.1021/bc000050t · Cited by 65
DNA Cleavage by Copper Complexes of 2‐ and 3‐Clip‐Phen Derivatives
Pitié, M., Boldron, C., Gornitzka, H., Hemmert, C., Donnadieu, B., & Meunier, B. (2003) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200390075 · Cited by 62
Oyoshi, T., & Sugiyama, H. (2000) · Journal of the American Chemical Society · doi:10.1021/ja9919130 · Cited by 60
Defazio, S., & Cini, R. (2002) · Journal of the Chemical Society Dalton Transactions · doi:10.1039/b107594m · Cited by 59
Terwel, D., Nieland, L. J. W., Schütte, B., Reutelingsperger, C. P. M., Ramaekers, F. C. S., & Steinbusch, H. W. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00379-4 · Cited by 59
Cai, X., Pan, N., & Zou, G. (2006) · BioMetals · doi:10.1007/s10534-006-9008-0 · Cited by 57
Zayed, M. A., El-Dien, F. A. N., Mohamed, G. G., & El‐Gamel, N. E. A. (2004) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2003.12.051 · Cited by 55
Hernández‐Esquivel, L., Marín‐Hernández, Á., Pavón, N., Carvajal, K., & Moreno‐Sánchez, R. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.06.023 · Cited by 55
Chen, R., Liu, C., Zhang, H., Guo, Y., Bu, X., & Yang, M. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.11.001 · Cited by 53
Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer
Kamat, A. M., DeHaven, J. I., & Lamm, D. L. (1999) · Urology · doi:10.1016/s0090-4295(99)00064-3 · Cited by 49
An overview of clinical trials involving inhibitors of angiogenesis and their mechanism of action
Gradishar, W. J. (1997) · Investigational New Drugs · doi:10.1023/a:1005770612294 · Cited by 46
Platinated Copper(3‐Clip‐Phen) Complexes as Effective DNA‐Cleaving and Cytotoxic Agents
Özalp‐Yaman, Ş., de Hoog, P., Amadei, G. A., Pitié, M., Gámez, P., Dewelle, J., Mijatovic, T., Meunier, B., Robert Kiss, A., & Reedijk, J. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200702021 · Cited by 46
Dallavalle, F., Gaccioli, F., Franchi‐Gazzola, R., Lanfranchi, M., Marchiò, L., Pellinghelli, M. A., & Tegoni, M. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00545-7 · Cited by 45
Copper-binding compounds as proteasome inhibitors and apoptosis inducers in human cancer
Kenyon, G. D. (2006) · Frontiers in bioscience · doi:10.2741/2054 · Cited by 42
Raptopoulou, C. P., Paschalidou, S., Pantazaki, Α. A., Terzis, A., Perlepes, S. P., Lialiaris, T. S., Bakalbassis, E. G., Mroziński, J., & Kyriakidis, D. A. (1998) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(98)10028-4 · Cited by 41
Bestwick, C. S., Milne, L., Pirie, L. P., & Duthie, S. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.10.005 · Cited by 37
G1-phase specific apoptosis in liver carcinoma cell line induced by copper-1,10-phenanthroline
Zhou, H., Zheng, C., Zou, G., Tao, D., & Gong, J. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00176-5 · Cited by 31
Wolohan, P., Yoo, J., Welch, M. J., & Reichert, D. E. C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0501376 · Cited by 29
de Hoog, P., Louwerse, M. J., Gámez, P., Pitié, M., Baerends, E. J., Meunier, B., & Reedijk, J. (2007) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200701052 · Cited by 24
Carballo, M., Vilaplana, R. A., MÁRQUEZ, G., Conde, M., Bedoya, F. J., González-Vílchez, F., & Sobrino, F. (1997) · Biochemical Journal · doi:10.1042/bj3280559 · Cited by 24
Booth, B. A., Agrawal, K., Moore, E. C., et al. (1974) · PubMed · Cited by 20
Cited by
Advances in Copper Complexes as Anticancer Agents
Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C. (2014) · Chemical Reviews · doi:10.1021/cr400135x · Cited by 1,790
Self-citationCopper in diseases and treatments, and copper‐based anticancer strategies
Tisato, F., Marzano, C., Porchia, M., Pellei, M., & Santini, C. (2010) · Medicinal Research Reviews · doi:10.1002/med.20174 · Cited by 797
Self-citationMetal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
Metal-NHC complexes: a survey of anti-cancer properties
Teyssot, M.-L., Jarrousse, A.-S., Manin, M., Chevry, A., Roche, S., Norre, F., Beaudoin, C., Morel, L., Boyer, D., Mahiou, R., et al. (2009) · Dalton Transactions · doi:10.1039/b906308k · Cited by 384
Nagai, M., Vo, N. H., Shin Ogawa, L., Chimmanamada, D., Inoue, T., Chu, J., Beaudette-Zlatanova, B. C., Lu, R., Blackman, R. K., Barsoum, J., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.03.017 · Cited by 357
Metadata
- Authors
- Marzano, C., Pellei, M., Tisato, F., & Santini, C.
- Venue
- Anti-Cancer Agents in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2009-02-01
- Volume
- 9
- Issue
- 2
- Pages
- 185-211
- ISSN
- 1568-0118 (ISSN-L)
- 1871-5206
- OpenAlex
- W2129658137
- Cited by
- 802
- References
- 138
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.